This Week in Policy – Wrap up for the week of March 31, 2025
HHS Mass Layoffs and Department Reorganization: The U.S. Department of Health and Human Services (HHS) announced significant layoffs, affecting around 10,000 full-time employees, as part of a major restructuring. This…
A Shift in Tone from the Top of HHS
In a series of recent political developments and restructuring within the U.S. Department of Health and Human Services (HHS), key figures and changes are shaping the future of American healthcare…
What to Expect for Liberation Day – Trump’s Tariffs and the Potential Impact on Hospitals
Tomorrow is the day that President Trump has designated as “Liberation Day” – the day he plans to implement retaliatory tariffs on trading partners. This initiative marks a significant escalation…
Major Reduction in Force at Health and Human Services – 10,000 Employees Cut
Today the U.S. Department of Health and Human Services (HHS) underwent a significant reduction in force (RIF) as part of a major restructuring initiative. This initiative resulted in the elimination…
Beyond the Lab: The Hidden Economic Impact of NIH Budget Cuts
The recent funding freeze imposed by DOGE on the National Institutes of Health (NIH) has had a significant impact on various states and universities across the United States. The funding…
This Week in Policy – Wrap up for the week of March 24, 2021
HHS to Cut 10,000 Jobs, Downsize Key Health Agencies The Department of Health and Human Services (HHS) will eliminate 10,000 full-time jobs, marking one of the largest federal health workforce…
HHS Funding Cuts Threaten Public Health Preparedness as States Brace for Fallout
The U.S. Department of Health and Human Services (HHS) is rescinding $11.4 billion in public health funding, cutting grants for infectious disease tracking, mental health services, and addiction treatment. …
Dr. Marty Makary Confirmed as FDA Commissioner, Ushering in a New Regulatory Era
Dr. Marty Makary, a Johns Hopkins surgeon and former Fox News contributor, has been confirmed as FDA Commissioner, marking a major shift in the agency’s direction under the Trump administration….
Dr. Jay Bhattacharya’s Nomination for NIH Director: Implications for Medical Research and Public Health
President Donald Trump has nominated Dr. Jay Bhattacharya, a professor of health policy at Stanford University, to serve as the next Director of the National Institutes of Health (NIH). Known…
mRNA Research Faces Uncertainty Amid Political and Funding Challenges
Recent developments indicate growing political and financial challenges for mRNA vaccine research, the technology that was instrumental in the rapid development of COVID-19 vaccines and is being explored for applications…